CSL’s Response to COVID-19
Despite the constantly challenging environment the COVID-19 pandemic has presented to the world, CSL has remained steadfast in our promise to safeguarding our patients, our plasma donors and our employees. As the pandemic continues to evolve, so have we. CSL has redirected resources and taken on extra commitments to protect public health where we could offer the most value, including our expertise, technologies, equipment and materials. And through it all, we continue to deliver on our promise for those who need us most, our patients.Read More About CSL's Efforts with COVID-19
CSL Publishes Vifor Offer Prospectus
CSL Behring AG Publishes Offer Prospectus On Public Tender Offer For All Publicly Held Shares Of Vifor Pharma Ltd.
CSL Welcomes US Court Ruling
Statement attributable to Greg Boss, Executive Vice President - Legal, and CSL Limited Group General Counsel.